Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($) $ in Thousands	Total	Common Shares	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2020	$ 136,003	$ 2	$ 183,015	$ (47,014)
Beginning Balance (in shares) at Dec. 31, 2020		23,410,348
Issuance of restricted common stock (in shares)		1,589,622
Share-based compensation expense	1,061		1,061
Net loss	(24,402)			(24,402)
Other comprehensive loss	0
Ending Balance (in shares) at Jun. 30, 2021		24,999,970
Ending Balance at Jun. 30, 2021	112,662	$ 2	184,076	(71,416)
Beginning Balance at Mar. 31, 2021	123,250	$ 2	183,537	(60,289)
Beginning Balance (in shares) at Mar. 31, 2021		24,990,263
Issuance of restricted common stock (in shares)		9,707
Share-based compensation expense	539		539
Net loss	(11,127)			(11,127)
Other comprehensive loss	0
Ending Balance (in shares) at Jun. 30, 2021		24,999,970
Ending Balance at Jun. 30, 2021	112,662	$ 2	184,076	(71,416)
Beginning Balance at Dec. 31, 2021	175,602	$ 3	269,626	(94,027)
Beginning Balance (in shares) at Dec. 31, 2021		32,129,970
Share-based compensation expense	4,701		4,701
Issuance of common stock under the stock award plan (in shares)		1,000
Net loss	(32,081)			(32,081)
Other comprehensive loss	(371)				$ (371)
Ending Balance (in shares) at Jun. 30, 2022		32,130,970
Ending Balance at Jun. 30, 2022	147,851	$ 3	274,327	(126,108)	(371)
Beginning Balance at Mar. 31, 2022	163,036	$ 3	271,680	(108,525)	(122)
Beginning Balance (in shares) at Mar. 31, 2022		32,130,970
Share-based compensation expense	2,647		2,647
Net loss	(17,583)			(17,583)
Other comprehensive loss	(249)				(249)
Ending Balance (in shares) at Jun. 30, 2022		32,130,970
Ending Balance at Jun. 30, 2022	$ 147,851	$ 3	$ 274,327	$ (126,108)	$ (371)